209 related articles for article (PubMed ID: 12460191)
1. Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes.
Walsh PT; Smith LM; O'Connor R
Immunology; 2002 Dec; 107(4):461-71. PubMed ID: 12460191
[TBL] [Abstract][Full Text] [Related]
2. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
Krause D; Lyons A; Fennelly C; O'Connor R
J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
[TBL] [Abstract][Full Text] [Related]
3. Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases.
Kenchappa P; Yadav A; Singh G; Nandana S; Banerjee K
J Neurosci Res; 2004 May; 76(4):466-74. PubMed ID: 15114618
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells.
Monno S; Newman MV; Cook M; Lowe WL
Endocrinology; 2000 Feb; 141(2):544-50. PubMed ID: 10650934
[TBL] [Abstract][Full Text] [Related]
5. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells.
Allen RT; Krueger KD; Dhume A; Agrawal DK
Apoptosis; 2005 May; 10(3):525-35. PubMed ID: 15909115
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase.
Okubo Y; Blakesley VA; Stannard B; Gutkind S; Le Roith D
J Biol Chem; 1998 Oct; 273(40):25961-6. PubMed ID: 9748273
[TBL] [Abstract][Full Text] [Related]
8. IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose.
Kang BP; Urbonas A; Baddoo A; Baskin S; Malhotra A; Meggs LG
Am J Physiol Renal Physiol; 2003 Nov; 285(5):F1013-24. PubMed ID: 12876069
[TBL] [Abstract][Full Text] [Related]
9. Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells.
Wadsworth TL; Carroll JM; Mallinson RA; Roberts CT; Roselli CE
Endocrinology; 2004 Jul; 145(7):3205-14. PubMed ID: 15033918
[TBL] [Abstract][Full Text] [Related]
10. Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis.
Skov S; Klausen P; Claesson MH
J Cell Biol; 1997 Dec; 139(6):1523-31. PubMed ID: 9396757
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways.
Hong F; Kwon SJ; Jhun BS; Kim SS; Ha J; Kim SJ; Sohn NW; Kang C; Kang I
Life Sci; 2001 Jan; 68(10):1095-105. PubMed ID: 11228094
[TBL] [Abstract][Full Text] [Related]
13. ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.
Smith JL; Schaffner AE; Hofmeister JK; Hartman M; Wei G; Forsthoefel D; Hume DA; Ostrowski MC
Mol Cell Biol; 2000 Nov; 20(21):8026-34. PubMed ID: 11027273
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells.
Sivaprasad U; Fleming J; Verma PS; Hogan KA; Desury G; Cohick WS
Endocrinology; 2004 Sep; 145(9):4213-21. PubMed ID: 15192040
[TBL] [Abstract][Full Text] [Related]
15. Activation of phosphatidylinositol 3-kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic beta-cell death.
Liu W; Chin-Chance C; Lee EJ; Lowe WL
Endocrinology; 2002 Oct; 143(10):3802-12. PubMed ID: 12239091
[TBL] [Abstract][Full Text] [Related]
16. Optimal chemotactic responses of leukemic T cells to stromal cell-derived factor-1 requires the activation of both class IA and IB phosphoinositide 3-kinases.
Curnock AP; Sotsios Y; Wright KL; Ward SG
J Immunol; 2003 Apr; 170(8):4021-30. PubMed ID: 12682230
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets.
Aikin R; Maysinger D; Rosenberg L
Endocrinology; 2004 Oct; 145(10):4522-31. PubMed ID: 15242986
[TBL] [Abstract][Full Text] [Related]
18. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death.
Kiely PA; Sant A; O'Connor R
J Biol Chem; 2002 Jun; 277(25):22581-9. PubMed ID: 11964397
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line.
Kodama Y; Baxter RC; Martin JL
Am J Respir Cell Mol Biol; 2002 Sep; 27(3):336-44. PubMed ID: 12204896
[TBL] [Abstract][Full Text] [Related]
20. The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation.
Hui L; Pei DS; Zhang QG; Guan QH; Zhang GY
Brain Res; 2005 Aug; 1052(1):1-9. PubMed ID: 16018989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
